Safety immunogenicity live hepatitis virus vaccine seronegative volunteers Seronegative adults dose-escalating study live hepatitis virus HAV vaccine variant HAV strain TCID HAV vaccine placebo months None vaccine recipients significant systemic reactions aminotransferase elevations HAV cell culture postvaccination serum stool specimen Antibody HAV modifications HAV antibody assays HAVAB HAVAB-M recipients vaccine dose order antibody present recipients months vaccination live attenuated HAV vaccine immunogenic dose 